BB Biotech AG/€BION
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About BB Biotech AG
BB Biotech AG is an investment company that focuses on investments in the biotechnology industry. The company is headquartered in Schaffhausen, Switzerland, and specializes in managing a portfolio primarily composed of companies involved in the development of innovative drugs and therapies. It seeks to capture growth opportunities in the biotech sector by investing in firms with cutting-edge scientific research and promising product pipelines. BB Biotech AG's investment strategy is informed by an in-depth analysis of market trends and scientific advancements, ensuring a dynamic and diversified portfolio. Its geographic footprint is primarily in Europe, with strategic investments in biotech firms globally.
Ticker
€BION
Sector
Primary listing
XGAT
Employees
10
Headquarters
Küsnacht, Switzerland
BB Biotech AG Metrics
BasicAdvanced
€2.6bn
3.04
€15.71
0.63
€2.46
5.15%
Price and volume
Market cap
€2.6bn
Beta
0.63
52-week high
€53.60
52-week low
€30.90
Average daily volume
15k
Dividend rate
€2.46
Financial strength
Current ratio
336.028
Quick ratio
335.836
Dividend payout ratio (TTM)
15.56%
Profitability
Gross margin (TTM)
100.00%
Net profit margin (TTM)
129.31%
Operating margin (TTM)
94.47%
Effective tax rate (TTM)
0.01%
Revenue per employee (TTM)
€66,768,930
Management effectiveness
Return on assets (TTM)
15.87%
Return on equity (TTM)
34.85%
Valuation
Price to earnings (TTM)
3.04
Price to revenue (TTM)
3.93
Price to book
0.93
Price to tangible book (TTM)
0.93
Price to free cash flow (TTM)
6.157
Free cash flow yield (TTM)
16.24%
Free cash flow per share (TTM)
7.755
Dividend yield (TTM)
5.15%
Forward dividend yield
5.15%
Growth
Revenue change (TTM)
-860.00%
Earnings per share change (TTM)
-286.53%
3-year revenue growth (CAGR)
5,262.66%
10-year revenue growth (CAGR)
8.80%
3-year earnings per share growth (CAGR)
36.72%
10-year earnings per share growth (CAGR)
-1.44%
3-year dividend per share growth (CAGR)
-7.58%
10-year dividend per share growth (CAGR)
-2.51%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
FAQs